Caroline Baumal Insider Profile
4 Followers
Caroline Baumal, CMO at Apellis Pharmaceuticals, holds 0.00 shares in Apellis Pharmaceuticals (Ticker: APLS).
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+31.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Caroline Baumal does not currently own shares as a corporate insider.
A breakdown of Caroline Baumal's holdings
Insider Roles
Caroline Baumal does not currently hold a role as a corporate insider.
Roles that Caroline Baumal holds in companies
Most Profitable Insider Trade
Stock:
Apellis Pharmaceuticals
(APLS)
(APLS)
Rating:Informative Sell
Date:Jan 05, 2024 - Jan 05, 2025
Return:+43.80%
The most profitable trade made by Caroline Baumal
Caroline Baumal's Trading History
List of latest transactions for each holding click on a transaction to see Caroline Baumal's performance on stock
You May Also Like
Caroline Baumal insider profile FAQ
What is the percentage of profitable transactions made by Caroline Baumal?
The percentage of profitable transactions made by Caroline Baumal is 100%.
What is the average return per transaction made by Caroline Baumal?
The average return per transaction made by Caroline Baumal is 31.50%.
What stocks does Caroline Baumal hold?
Caroline Baumal holds: APLS stocks.
What was Caroline Baumal’s latest transaction?
Caroline Baumal latest transaction was an Uninformative Buy of ―.
What was Caroline Baumal's most profitable transaction?
Caroline Baumal’s most profitable transaction was an Informative Sell of APLS stock on January 5, 2024. The return on the trade was 43.80%.
What is Caroline Baumal's role in Apellis Pharmaceuticals?
Caroline Baumal's role in Apellis Pharmaceuticals is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.